Site Map
Posts
- Category: Wp Feeds (continued)
- FDA Bans Off-Label Cephalosporin Use in Animals
- FDA Breaks New Ground with Expanded Keytruda Indication
- FDA Broadens Use for Alvimopan
- FDA Clears Pancreatic Pseudocyst Stent
- FDA Clears Test for 11 GI Pathogens
- FDA Committee Takes Second Look at Essure Contraceptive
- FDA Drug Approvals Hit 19-Year High
- FDA Finalizes New Food Safety Rules
- FDA Gives Nod to Aflibercept for Colon Cancer
- FDA Gives Nod to Incontinence Gel
- FDA Greenlights First Norovirus Test
- FDA Greenlights New Oral Steroid for Colitis
- FDA Guidance on 3D Printing a 'First Step'
- FDA Issues Warning on Acid Reflux Drugs
- FDA Issues Warning on IBS Drug Viberzi
- FDA Leaders' Vaccination Warning; Michael Bolton's Brain Tumor; JN.1 Now Dominant
- FDA Offers New Guidance on Duodenoscope Cleaning
- FDA Officials Detail Plan to Limit COVID Shots
- FDA Okays Finger Stick for Hep C Test
- FDA Okays First Rapid HCV Test
- FDA Okays Novel Gel to Curb Bleeding During Surgery
- FDA Okays Two Drugs for Irritable Bowel Syndrome
- FDA OKs Abraxane for Pancreatic Cancer
- FDA OKs Blood Bag Tracking Device
- FDA OKs Colon Cleanse Powder
- FDA OKs Drug for Opioid-Induced Constipation
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Gattex for Short Bowel Syndrome
- FDA OKs Generic Xeloda
- FDA OKs Hep C Indication for Promacta
- FDA OKs Implant to Treat GERD
- FDA OKs PML Risk Test for Patients on Tysabri
- FDA Orders Duodenoscope Makers to Conduct Studies on Use
- FDA Orders Ovarian Failure, VTE Risks for Avastin Label
- FDA Panel Backs Biosimilar for Humira
- FDA Panel Backs CT Colonography
- FDA Panel Backs HCV Drugs
